4//SEC Filing
Farkas Charles 4
Accession 0001127602-25-016762
CIK 0000816956other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 5:35 PM ET
Size
11.8 KB
Accession
0001127602-25-016762
Insider Transaction Report
Form 4
CONMED CorpCNMD
Farkas Charles
Director
Transactions
- Award
RSUs (Restricted Stock Units)
2025-06-02+668→ 668 totalExercise: $0.00From: 2026-06-02Exp: 2035-06-02→ Common Stock (668 underlying) - Award
Options To Purchase Common Stock
2025-06-02+8,061→ 8,061 totalExercise: $55.38From: 2026-06-02Exp: 2035-06-02→ Common Stock (8,061 underlying) - Exercise/Conversion
RSUs (Restricted Stock Units)
2025-06-03−479→ 0 totalExercise: $0.00From: 2025-06-03Exp: 2034-06-03→ Common Stock (479 underlying) - Exercise/Conversion
Common Stock
2025-06-03+479→ 16,859 total
Footnotes (3)
- [F1]The stock options were granted under the Company's 2025 Long-Term Incentive Plan and generally vest 100% after a one year period.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.
- [F3]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.
Documents
Issuer
CONMED Corp
CIK 0000816956
Entity typeother
Related Parties
1- filerCIK 0001615538
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 5:35 PM ET
- Size
- 11.8 KB